Dagmar Rosa Bjorkeson Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

Dagmar Rosa Bjorkeson is Director of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 11,625 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $220,875. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

DAGMAR ROSA-BJORKESON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Sale (or disposition) back to the issuer	$220,875 $19.0 p/Share	11,625 Reduced 100.0%	0 Common Stock
Nov 08 2023	SELL Disposition due to a tender of shares in a change of control transaction	$280,554 $19.0 p/Share	14,766 Reduced 100.0%	0 Common Stock
May 24 2023	BUY Grant, award, or other acquisition	-	8,111 Added 23.51%	26,391 Common Stock
May 25 2022	BUY Grant, award, or other acquisition	-	7,737 Added 29.74%	18,280 Common Stock
May 27 2021	BUY Grant, award, or other acquisition	-	10,543 Added 50.0%	10,543 Common Stock

Also insider at

XNCR

Xencor Inc Healthcare

Director